Brean Murray Carret & Co. maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Removes From N-T Focus List, But Dip Offers Investor Opportunity

Go back to Brean Murray Carret & Co. maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Removes From N-T Focus List, But Dip Offers Investor Opportunity
Achillion Pharmaceuticals, Inc. (AMEX: ACHN) Delayed: 0.79 --0 (-0%)
Previous Close $0.79    52 Week High $10.95 
Open $15.10    52 Week Low $3.78 
Day High $0.79    P/E N/A 
Day Low $0.79    EPS $-0.63 
Volume 504,330       

Bristol-Myers Squibb (NYSE: BMY) Delayed: 63.83 -0.82 (1.27%)
Previous Close $64.65    52 Week High $77.12 
Open $64.13    52 Week Low $49.03 
Day High $64.33    P/E 41.45 
Day Low $63.35    EPS $1.54 
Volume 7,529,798       

Gilead Sciences (NASDAQ: GILD) Delayed: 138.36 +0.22 (0.16%)
Previous Close $138.14    52 Week High $108.63 
Open $136.81    52 Week Low $71.39 
Day High $138.43    P/E 76.44 
Day Low $135.91    EPS $1.81 
Volume 3,407,717